Biofrontera
BFRIW
2 hedge funds and large institutions have $396K invested in Biofrontera in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
2.34% more ownership
Funds ownership: 0% → 2.34% (+2.3%)
60% less funds holding
Funds holding: 5 → 2 (-3)
64% less capital invested
Capital invested by funds: $1.11M → $396K (-$712K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$67K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$19.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$4.5K |
BFRIW Hedge Fund Activity: Q1 2022 in Review
2 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q1 2022, worth a combined $396K — down 64% from $1.11M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BFRIW and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Warberg Asset Management, exiting entirely with an estimated $67K sold.
- 2 institutional investors held Biofrontera (BFRIW) as of Q1 2022, down from 5 in Q4 2021.
- Funds reported $396K of Biofrontera stock for Q1 2022, down 64% quarter-over-quarter.
- 0 funds opened new Biofrontera positions in Q1 2022 and 3 closed out, a net change of -3 holders.
- The largest Biofrontera seller in Q1 2022 was Warberg Asset Management, an estimated $67K sold.
Based on aggregated 13F filings for Q1 2022.